The DOI matches its Crossref record; 43 of the 46 references it cites were found in a registry or an index.
Expression of separate isoforms of human tau protein: correlation with the tau pattern in brain and effects on tubulin polymerization.
Open accessAbstract
We have expressed six previously cloned isoforms of human microtubule-associated tau protein in Escherichia coli and purified them to homogeneity in a biologically active form. They range from 352 to 441 amino acids in length and differ from each other by the presence of three or four tandem repeats in the carboxy-terminal half and by the presence or absence of 29 or 58 amino acid inserts in the amino-terminus. When mixed together they gave a set of six bands on SDS-PAGE gels with apparent molecular weights of 48-67 kd and with a characteristic pattern of spacings. Four of these bands aligned with the major tau bands found in adult human cerebral cortex following perchloric acid extraction and alkaline phosphatase treatment. They consisted of isoforms with three repeats and no insertions, four repeats and no amino-terminal insertions and three- and four-repeat containing isoforms with the 29 amino acid insertion. In fetal human brain extracts treated with alkaline phosphatase one of the two major tau bands aligned with the three-repeat containing isoform with no insertions, whereas the molecular nature of the second major tau band remains to be established. The recombinant tau isoforms were biologically active at micromolar concentrations, as assessed by their ability to promote microtubule assembly. The rates of assembly were 2.5-3.0 times faster for isoforms containing four repeats when compared with three-repeat containing isoforms, with no significant contribution by the amino-terminal insertions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Since tau binds to microtubules through C-terminal repeats within the microtubule-binding domain, 4R tau isoforms show a higher propensity to promote microtubule assembly compared to 3R tau isoforms [122, 123].”
From Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease (2020) · cites this paper as [123]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
Raza, H., John, A., & Nemmar, A. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350087 · Cited by 47,311
[6] Use of T7 RNA polymerase to direct expression of cloned genes
Studier, F. W., Rosenberg, A. H., Dunn, J. J., & Dubendorff, J. W. (1990) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(90)85008-c · Cited by 6,562
Matsudaira, P. T. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)61070-1 · Cited by 4,951
A protein factor essential for microtubule assembly
Weingarten, M. D., Lockwood, A. H., Hwo, S. Y., & Kirschner, M. W. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.5.1858 · Cited by 3,089
Goedert, M., Spillantini, M. G., Jakes, R., Rutherford, D., & Crowther, R. A. (1989) · Neuron · doi:10.1016/0896-6273(89)90210-9 · Cited by 2,492
Self-citationMicrotubule-associated protein tau. A component of Alzheimer paired helical filaments.
Grundke, I., Iqbal, K., Quinlan, M., Tung, Y. C., Zaidi, M. S., & Wisniewski, H. M. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38495-8 · Cited by 1,780
The distribution of tau in the mammalian central nervous system.
Binder, L. I., Frankfurter, A., & Rebhun, L. I. (1985) · The Journal of cell biology · doi:10.1083/jcb.101.4.1371 · Cited by 1,588
Kosik, K. S., Joachim, C. L., & Selkoe, D. J. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.11.4044 · Cited by 1,491
Goedert, M., Wischik, C. M., Crowther, R. A., Walker, J. E., & Klug, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.11.4051 · Cited by 1,134
Self-citation
Research works printed but not linked: 7
- Goedert,M., Wischik,C.M., Crowther,R.A., Walker,J.E. and Klug,A. (1988) Proc. Natl. Acad. Sci. USA, 85, 4051-4055.
- Hirel,P.H., Schmitter,J.M., Dessen,P., Fayat,G. and Blanquet,S. (1989) Proc. Natl. Acad. Sci. USA, 86, 8247-8251.
- Kosik,K.S., Joachim,C.L. and Selkoe,D.J. (1986) Proc. Natl. Acad. Sci. USA, 83, 4044-4048.
- Weingarten,M.D., Lockwood,A.H., Hwo,S.Y. and Kirschner,M.W. (1975) Proc. Natl. Acad. Sci. USA, 72, 1858-1862.
- Wischik,C.M., Novak,M., Th0gersen,H.C., Edwards,P.C., Runswick,M.J., Jakes,R., Walker,J.E., Milstein,C., Roth,M. and Klug,A. (1988a) Proc. Natl. Acad. Sci. USA, 85, 4506-4510.
- Wischik,C.M., Novak,M., Edwards,P.C., Klug,A., Tichelaar,W. and Crowther,R.A. (1988b) Proc. Natl. Acad. Sci. USA, 85, 4884-4888.
- Wood,J.G., Mirra,S.S., Pollock,N.J. and Binder,L.I. (1986) Proc. Natl. Acad. Sci. USA, 83, 4040-4043. Received on August 28, 1990 4230 14602075, 1990, 13, Downloaded from https://www.embopress.org/doi/10.1002/j.1460-2075.1990.tb07870.x by Readcube (Labtiva Inc.), Wiley Online Library on [14/08/2023]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License · DOI
Cited by
Sorted by citations
Items 501–600 of 929
Analytical Aspects of Molecular Alzheimer’s Disease Biomarkers
Andréasson, U., Vanmechelen, E., Shaw, L. M. J., Zetterberg, H., & Vanderstichele, H. (2012) · Biomarkers in Medicine · doi:10.2217/bmm.12.44 · Cited by 26
Rojas, A. V., Maisuradze, G. G., & Scheraga, H. A. (2018) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.8b04647 · Cited by 28
Ivashko‐Pachima, Y., & Gozes, I. (2020) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2020.07.008 · Cited by 25
The Structure Biology of Tau and Clue for Aggregation Inhibitor Design
Wang, D., Huang, X., Yan, L., Zhou, L., Chang, Y., Wu, J., Su, Z., & Huang, Y. (2021) · The Protein Journal · doi:10.1007/s10930-021-10017-6 · Cited by 27
Peña‐Ortega, F., Robles-Gómez, Á. A., & Cueva, L. X. (2022) · Cells · doi:10.3390/cells11060923 · Cited by 31
Jin, M., Wang, S., Gao, X., Zou, Z., Hirotsune, S., & Sun, L. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.382231 · Cited by 27
“On the other hand, in mice, only 4R tau is exclusively present in the adult brain, and 3R isoforms are predominant during the developmental stage of the embryonic brain (Lee et al., 1988; Goedert and Jakes, 1990).”
BackgroundDistinct Neurotoxic Effects of Extracellular Tau Species in Primary Neuronal-Glial Cultures
Pampuščenko, K., Morkūnienė, R., Krasauskas, L., Smirnovas, V., Tomita, T., & Borutaitė, V. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02150-7 · Cited by 28
Paired helical filaments in corticobasal degeneration: the fine fibrillary structure with NanoVan
Tracz, E., Dickson, D. W., Hainfeld, J. F., & Ksiȩżak-Reding, H. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00830-5 · Cited by 26
In Vivo Analysis of Wild‐type and FTDP‐17 Tau Transgenic Mice
Götz, J., Barmettler, R., Ferrari, A., Goedert, M., Probst, A., & Nitsch, R. M. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06914.x · Cited by 26
Self-citationPatmanidi, A. L., Possee, R. D., & King, L. A. (2003) · Virology · doi:10.1016/j.virol.2003.08.035 · Cited by 26
Neumann, M., Mittelbronn, M. G. A., Simon, P. D., Vanmassenhove, B., de Silva, R., Lees, A. J., Klapp, J., Meyermann, R., & Kretzschmar, H. A. (2005) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2005.00629.x · Cited by 26
A Novel MAPT Mutation, G55R, in a Frontotemporal Dementia Patient Leads to Altered Tau Function
Iyer, A., LaPointe, N. E., Zielke, K., Berdyński, M., Guzman, E., Barczak, A. K., Chodakowska-Żebrowska, M., Barcikowska, M., Feinstein, S. C., & Żekanowski, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076409 · Cited by 27
“However, the functional differences between these three different tau isoforms (generally denoted as 0N, 1N or 2N, respectively) are poorly understood [47].”
BackgroundTherapeutic and diagnostic challenges for frontotemporal dementia
Dâ€TMAlton, S., & Lewis, J. M. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00204 · Cited by 26
Drug Development in Alzheimer’s Disease: The Contribution of PET and SPECT
Declercq, L., Vandenberghe, R. R., Laere, K. V., Verbruggen, A., & Bormans, G. M. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00088 · Cited by 27
“The exact physiological role of these various isoforms remains to be elucidated, although 4R isoforms are better at promoting microtubuli assembly, and have greater binding affinity for microtubuli than the 3R isoforms (Goedert and Jakes, 1990; Butner and Kirschner, 1991).”
BackgroundAbsence of a Role for Phosphorylation in the Tau Pathology of Alzheimer’s Disease
Lai, R. Y. K., Harrington, C. R., & Wischik, C. M. (2016) · Biomolecules · doi:10.3390/biom6020019 · Cited by 24
Coexistent Tau and Amyloid Pathology in Hereditary Frontotemporal Dementia with Tau Mutations
Rosso, S. M., Kamphorst, W., Ravid, R., & Swieten, J. C. V. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06912.x · Cited by 25
Phenotypic Variation in Frontotemporal Dementia and Parkinsonism Linked to Chromosome 17
Swieten, J. C. V., Rosso, S. M., van Herpen, E., Kamphorst, W., Ravid, R., & Heutink, P. (2004) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000077150 · Cited by 25
Molecular characterization of dendritically localized transcripts encoding MAP2
Kindler, S., Müller, R., Chung, W. J., & Garner, C. C. (1996) · Molecular Brain Research · doi:10.1016/0169-328x(95)00237-m · Cited by 25
Tau Interacting Proteins: Gaining Insight into the Roles of Tau in Health and Disease
Stancu, I., Ferraiolo, M., Terwel, D., & Dewachter, I. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-32-9358-8_13 · Cited by 23
Ng, P. Y., Chang, I. S., Koh, R. Y., & Chye, S. M. (2020) · Metabolic Brain Disease · doi:10.1007/s11011-020-00591-6 · Cited by 25
“There are six isoforms of Tau derived from alternative splicing of mRNA in the brain of an adult (Fá et al., 2016; Goedert and Jakes, 1990).”
BackgroundDissecting the Binding Profile of PET Tracers to Corticobasal Degeneration Tau Fibrils
Zhou, Y., Li, J., Nordberg, A. K., & Ågren, H. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00536 · Cited by 24
Künze, G., Kümpfel, R., Rullmann, M., Barthel, H., Brendel, M., Patt, M., & Sabri, O. (2022) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00291 · Cited by 22
Gerez, J., Prymaczok, N. C., Kadavath, H., Ghosh, D., Bütikofer, M., Fleischmann, Y., Güntert, P., & Riek, R. (2022) · Communications Biology · doi:10.1038/s42003-022-04251-6 · Cited by 23
Hoq, M. R., Bharath, S. R., Hallinan, G. I., Fernández, A., Vago, F. S., Ozcan, K. A., Li, D., Garringer, H. J., Vidal, R., Ghetti, B. F., et al. (2023) · Acta Neuropathologica · doi:10.1007/s00401-023-02563-3 · Cited by 24
“Depending on the isoforms involved in the specific disorder [13], tau aggregates are found in neurons or in neurons, astrocytes and oligodendrocytes in the gray matter; whereas, tau aggregates are found in oligodendrocytes and astrocytes in the white matter.”
BackgroundNeuronal expression of pathological tau accelerates oligodendrocyte progenitor cell differentiation
Ossola, B., Zhao, C., Compston, A., Pluchino, S., Franklin, R. J. M., & Spillantini, M. G. (2015) · Glia · doi:10.1002/glia.22940 · Cited by 27
“To test this hypothesis, we exposed OPCs isolated from Wt mice to filamentous and hyperphosphorylated tau obtained by sarkosyl extraction of spinal cords of 5-month-old P301S-htau mice as previously described (Goedert and Jakes, 1990).”
Menadione-induced tau dephosphorylation in cultured human neuroblastoma cells
Ko, L., Odawara, T., & Yen, S.-H. C. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00292-8 · Cited by 24
Księżak-Reding, H., Shafit-Zagardo, B., & Shu, H.-Y. C. (1995) · Journal of Neuroscience Research · doi:10.1002/jnr.490410504 · Cited by 22
Modulation of Tau Pathology in Alzheimer’s Disease by Dietary Bioactive Compounds
Shi, H., & Zhao, Y. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25020831 · Cited by 26
“In mature human brain, the 3R and 4R tau isoforms are found in approximately equal molar ratios [23,24].”
BackgroundMutreja, Y., Combs, B., & Gamblin, T. C. (2018) · Biochemistry · doi:10.1021/acs.biochem.8b01039 · Cited by 29
Intraneuronal Tau Misfolding Induced by Extracellular Amyloid-β Oligomers
Rudenko, L. K., Wallrabe, H. K., Periasamy, A., Siller, K. H., Švindrych, Z., Seward, M. E., Best, M. N., & Bloom, G. S. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190226 · Cited by 24
“…acids each near its N-terminus, a proline-rich region with many potential phosphorylation sites located near the end of the N-terminal half of the protein, and 3 or 4 imperfect, tandem microtubule-binding repeat domains (MTBRs) of 31 or 32 amino acids each located in the C-terminal half [7, 8].”
Prion-like strain effects in tauopathies
Han, Z. Z., Kang, S., Arce, L., & Westaway, D. A. (2022) · Cell and Tissue Research · doi:10.1007/s00441-022-03620-1 · Cited by 24
“Due to the additional repeat motif R2, 4R tau displays a higher affinity to microtubules than 3R tau and is thus more efficient at mediating microtubule assembly (Goedert and Jakes 1990).”
BackgroundTau Protein as Therapeutic Target for Cancer? Focus on Glioblastoma
Hedna, R., Kovacic, H., Pagano, A., Peyrot, V., Robin, M., Devred, F., & Breuzard, G. (2022) · Cancers · doi:10.3390/cancers14215386 · Cited by 25
“Note that the shortest Tau isoform without exons 2, 3, 4a, and 10 (also called “fetal Tau”) is predominantly expressed in the fetal brain [36,37].”
BackgroundNeurodegeneration risk factor, EIF2AK3 (PERK), influences tau protein aggregation
Park, G., Xu, K., Chea, L., Kim, K., Safarta, L. A., Song, K., Wu, J., Park, S., Min, H., Hiramatsu, N., et al. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102821 · Cited by 25
“Alternative splicing of the MAPT transcript generates 6 tau protein isoforms that carry varying numbers of carboxy-terminal repeat (R) domains (5,9,10).”
BackgroundKorn, L., Speicher, A. M., Schroeter, C. B., Gola, L., Kaehne, T., Engler, A., Disse, P., Fernández‐Orth, J., Csatári, J., Naumann, M., et al. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102597 · Cited by 24
Phospholipids and calmodulin modulate the inhibition of PMCA activity by tau
Berrocal, M., Corbacho‐Cuello, I., Sepúlveda, M. R., Gutiérrez‐Merino, C., & Mata, A. M. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2016.10.023 · Cited by 23
Garver, T. D., Kincaid, R. L., Conn, R. A., & Billingsley, M. L. (1999) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)23024-8 · Cited by 41
“The extent of t phosphorylation is a major determinant of its ability to bind and therefore regulate microtubule assembly (Goedert and Jakes, 1990).”
BackgroundBuchholz, S., Kabbani, M. A. A., Bell‐Simons, M., Kluge, L., Cagmak, C., Klimek, J., Haag, N., Iohan, L. D. C. C., Coulon, A., Costa, M. R., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.14403 · Cited by 21
Tubulin modifying enzymes as target for the treatment of tau-related diseases
Rogowski, K., Hached, K., Crozet, C., & van der Laan, S. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107681 · Cited by 21
Olesen, M. A., & Quintanilla, R. A. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03434-4 · Cited by 23
“It is well understood that tau stabilizes and polymerizes microtubules which are vital for the axonal transport of organelles, proteins, and lipids by anterograde and retrograde movement through motor proteins such as kinesin (anterograde transport) and dynein (retrograde transport) [40, 41].”
BackgroundYeboah, F., Kim, T., Bill, A., & Dettmer, U. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104543 · Cited by 22
Delobel, P., Flament, S., Hamdane, M., Delacourte, A., Vilain, J., & Buée, L. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)02525-5 · Cited by 22
Progressive supranuclear palsy: clinical and genetic aspects
Pástor, P., & TOLOSA, E. S. (2002) · Current Opinion in Neurology · doi:10.1097/00019052-200208000-00005 · Cited by 22
Human protein tau represses DNA replication in vitro
Li, W., Wang, X. S., Qu, M., Liu, Y. M., & He, R. Q. (2005) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2005.08.014 · Cited by 23
Differential phosphorylation of tau proteins during kitten brain development and Alzheimer's disease
Riederer, B. M., Mourton-Gilles, C., Frey, P., Delacourte, A., & Probst, A. (2001) · Journal of Neurocytology · doi:10.1023/a:1011991207942 · Cited by 22
Brain Damage - Bridging Between Basic Research and Clinics
González-Quevedo, A. (2012) · InTech eBooks · doi:10.5772/2174 · Cited by 21
Altered Proteostasis in Neurodegenerative Tauopathies
Papanikolopoulou, K., & Skoulakis, E. M. C. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-38266-7_7 · Cited by 23
Su, J., Xiao, Y., Wang, X., Zheng, J., & Wang, J. (2024) · Medicine Plus · doi:10.1016/j.medp.2024.100060 · Cited by 23
Spillantini, M. G., Murrell, J. R., Goedert, M., Farlow, M. R., Klug, A., & Ghetti, B. F. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-9s342 · Cited by 21
“It was well established that upon dephosphorylation soluble tau from normal human cerebral cortex runs as four strong and two weak bands on SDS-PAGE, which align with the six recombinantly expressed human brain isoforms [8, 9].”
Self-citationTau Pathology and Adult Hippocampal Neurogenesis: What Tau Mouse Models Tell us?
Houben, S., Homa, M., Yılmaz, Z., Leroy, K., Brion, J., & Ando, K. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.610330 · Cited by 17
“Owing to the lack of one microtubule-binding domain, 3R tau isoforms have less affinity for microtubules and consequently less efficiency to promote microtubule assembly compared to 4R isoforms (56).”
BackgroundDistinct lipid membrane-mediated pathways of Tau assembly revealed by single-molecule analysis
Yao, Q.-Q., Wen, J., Perrett, S., & Wu, S. (2022) · Nanoscale · doi:10.1039/d1nr05960b · Cited by 22
Du, J., Yu, C., Zhou, L., Wu, W., Lei, P., Li, Y., Zhao, Y., Nakanishi, H., & Li, Y. (2007) · FEBS Journal · doi:10.1111/j.1742-4658.2007.06018.x · Cited by 21
Neill, D. (2011) · Ageing Research Reviews · doi:10.1016/j.arr.2011.06.004 · Cited by 22
Retromer dysfunction at the nexus of tauopathies
Carosi, J. M., Denton, D., Kumar, S., & Sargeant, T. J. (2021) · Cell Death & Differentiation · doi:10.1038/s41418-020-00727-2 · Cited by 16
Differential Regulation of Tau Exon 2 and 10 Isoforms in Huntington’s Disease Brain
Petry, S., Nateghi, B., Keraudren, R., Sergeant, N., Planel, E., Hébert, S. S., & St‐Amour, I. (2022) · Neuroscience · doi:10.1016/j.neuroscience.2022.07.014 · Cited by 20
Brain Regional Identity and Cell Type Specificity Landscape of Human Cortical Organoid Models
Magni, M., Bossi, B., Conforti, P., Galimberti, M., Dezi, F., Lischetti, T., He, X., Barker, R., Zuccato, C., Espuny-Camacho, I., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113159 · Cited by 22
“We confirmed that the pattern of expression of 4R TAU varies between embryonic and adult stages in humans (Figure 3J) [24,40].”
BackgroundStructure of NFT: Biochemical Approach
Hasegawa, M. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-32-9358-8_2 · Cited by 22
Ferhat, L., Represa, A., Ferhat, W., Ben‐Ari, Y., & Khrestchatisky, M. (1998) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1998.00044.x · Cited by 20
Utton, M. A., Gibb, G., Burdett, I. D. J., Anderton, B. H., & Vandecandelaere, A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011384200 · Cited by 20
Growth factor stimulation triggers apoptotic cell death in mature oligodendrocytes
Muir, D., & Compston, D. A. S. (1996) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19960401)44:1 · Cited by 68
Hernández‐Hernández, Ó., de León, M. B., Gómez, P., Velázquez‐Bernardino, P., García‐Sierra, F., & Cisneros, B. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.20989 · Cited by 20
“As exon 10 encodes an additional microtubule binding domain its inclusion enhances the microtubule-binding activity of s (Goedert and Jakes, 1990; Lu and Kosik, 2001).”
BackgroundSpecific macromolecular interactions between tau and the microtubule system
Far�as, G. A., Vial, C., & Maccioni, R. B. (1992) · Molecular and Cellular Biochemistry · doi:10.1007/bf00229646 · Cited by 20
“1) are equivalent to the first (V247-G264), third (V3°9-G 326) and fourth (V341-G 358) tau repeats found in some isoforms of the adult brain [11, 30].”
BackgroundOtto, M., & Wiltfang, J. (2003) · Restorative Neurology and Neuroscience · doi:10.3233/rnn-2003-00238 · Cited by 20
“In the brain of an adult, the ratio of 3R-tau to 4R-tau isoforms is around 1:1 [159].”
Evolving concepts of chronic traumatic encephalopathy as a neuropathological entity
Ling, H., Neal, J., & Révész, T. (2017) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12425 · Cited by 19
Focal cerebral ischemia induces changes in oligodendrocytic tau isoforms in the damaged area
Villa-González, M., Vallés‐Saiz, L., Hernández, I. H., Ávila, J., Hernández, F., & Pérez-Álvarez, M. J. (2020) · Glia · doi:10.1002/glia.23865 · Cited by 19
“The six adult isoforms vary in the presence or absence of Exons 2, 3, and 10 (Goedert & Jakes, 1990).”
BackgroundMical modulates Tau toxicity via cysteine oxidation in vivo
Prifti, E., Tsakiri, E. N., Vourkou, E., Stamatakis, G. M., Samiotaki, M. K., Skoulakis, E. M. C., & Papanikolopoulou, K. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01348-1 · Cited by 21
“a greater affinity than 3R species and extensive phosphorylation reduces binding efficiency [4, 5].”
BackgroundHromádková, L., Siddiqi, M. K., Liu, H., & Safar, J. (2022) · Cells · doi:10.3390/cells11192997 · Cited by 19
“Overall, alternative splicing results in six tau isoforms that differ by the presence or absence of two N-terminal regions (0 N, 1 N, or 2 N) as well as conserved repeat motifs (3R or 4R) [94,95].”
BackgroundSong, Z., Gatch, A. J., Sun, Y., & Ding, F. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00014 · Cited by 21
Rzechorzek, N. M., Connick, P., Livesey, M. R., Borooah, S., Patani, R., Burr, K., Story, D., Wyllie, D. J. A., Hardingham, G. E., & Chandran, S. (2015) · EBioMedicine · doi:10.1016/j.ebiom.2015.12.010 · Cited by 20
“These isoforms differ by their number of repeated microtubule binding domains; three repeat (3R) tau predominates during early development, whilst approximately equal levels of 3R and 4R tau exist in the mature brain (Goedert et al., 1989b; Goedert and Jakes, 1990).”
BackgroundWobst, H. J., Denk, F., Oliver, P., Livieratos, A., Taylor, T. N., Knudsen, M. H., Bengoa-Vergniory, N., Bannerman, D., & Wade-Martins, R. (2017) · Scientific Reports · doi:10.1038/srep43198 · Cited by 17
From 1997 to 2007: A decade journey through the H1 haplotype on 17q21 chromosome
Kalinderi, K., Fidani, L., & Bostantjopoulou, S. (2008) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2008.03.001 · Cited by 19
“The 4R tau isoform binds to microtubules threefold more strongly and assembles microtubules more efficiently than 3R tau [6].”
BackgroundThe pathology of the neuronal cytoskeleton in Alzheimer's disease
Brion, J. (1992) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/0167-4838(92)90047-h · Cited by 19
Tau protein aggregation associated with SARS-CoV-2 main protease
Eberle, R. J., Coronado, M. A., Gering, I., Sommerhage, S., Korostov, K., Stefanski, A., Stühler, K., Kraemer‐Schulien, V., Blömeke, L., Bannach, O., et al. (2023) · PLoS ONE · doi:10.1371/journal.pone.0288138 · Cited by 19
“However, the protein presented a single band on a denaturing SDS-PAGE gel with an apparent molecular mass of around 67 kDa, this behavior was described previously [42, 43].”
BackgroundGozes, I., & Ivashko‐Pachima, Y. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00205 · Cited by 18
“…splicing around exon 10 of the tau transcript yields tau protein variants including tau protein containing either 3 or 4 microtubule binding repeat domains (tau 3R or 4R), associated with dynamic and stable microtubules, respectively (Goedert et al., 1988, 1989a,b; Goedert and Jakes, 1990).”
BackgroundElevation of casein kinase 1ε associated with TDP‐43 and tau pathologies in Alzheimer's disease
Gu, J., Hu, W. H., Tan, X., Qu, S., Chu, D., Gong, C., Iqbal, K., & Liu, F. (2019) · Brain Pathology · doi:10.1111/bpa.12775 · Cited by 19
“In normal adult human brain, approximately equal levels of 3R- and 4R-tau are expressed (18).”
BackgroundLemke, N., Melis, V., Lauer, D., Magbagbeolu, M., Neumann, B., Harrington, C. R., Riedel, G., Wischik, C. M., Theuring, F., & Schwab, K. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.014890 · Cited by 15
“This has been shown to be due to altered affinity for SDS, which has the effect of retarding their electrophoretic mobility in gels (5, 44).”
BackgroundMolecular cloning of XTP, a tau-like microtubule-associated protein from Xenopus laevis tadpoles
Olesen, O. F., Kawabata-Fukui, H., Yoshizato, K., & Noro, N. (2002) · Gene · doi:10.1016/s0378-1119(01)00869-1 · Cited by 18
Probing modifications of the neuronal cytoskeleton
Doering, L. C. (1993) · Molecular Neurobiology · doi:10.1007/bf02769179 · Cited by 18
Tangles and Plaques: A deep dive into the pathological hallmarks of Alzheimer’s disease
Vanya, Kumari, S., Bagri, K., & Deshmukh, R. R. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.10.050 · Cited by 18
Costa, A. J., Oliveira, R. B., Wachilewski, P., Nishino, M. S., Bassani, T. B., Stilhano, R. S., Cerutti, J. M., Nozima, B. H. N., Porto, C. S., Pereira, G. J. S., et al. (2022) · Brain Research · doi:10.1016/j.brainres.2022.148079 · Cited by 17
Padmanabhan, P., Kneynsberg, A., Cruz, E., Amor, R., Sibarita, J., & Götz, J. (2022) · The EMBO Journal · doi:10.15252/embj.2022111265 · Cited by 15
“Previous studies have shown that different recombinant forms of Tau have different aggregation rates and filament formation capabilities in cell-free conditions (Goedert & Jakes, 1990; King et al , 2000).”
Presence of Phosphorylated Tau Protein in the Skin of Alzheimer´s Disease Patients
Guadalupe, G. (2015) · Journal of Molecular Biomarkers & Diagnosis · doi:10.4172/2155-9929.s6-005 · Cited by 17
“We confirm here by means of Western blot the presence of p-Tau in the skin showing a similar molecular weight as in other organs [20-22].”
BackgroundTargeting of Disordered Proteins by Small Molecules in Neurodegenerative Diseases
Longhena, F., Spano, P., & Bellucci, A. (2017) · Handbook of experimental pharmacology · doi:10.1007/164_2017_60 · Cited by 17
Synthesis and conformational properties of phosphopeptides related to the human tau protein
Du, J., Li, Y., Ma, Q., Wei, Q., Zhao, Y., Abe, H., Kanazawa, K., Qin, X., Aoyagi, R., Ishizuka, Y., et al. (2005) · Regulatory Peptides · doi:10.1016/j.regpep.2005.03.003 · Cited by 17
Phosphorylation of tau protein in tau-transfected 3T3 cells
Sygowski, L. A., Fieles, A. W., Lo, M. M. S., Scott, C. W., & Caputo, C. B. (1993) · Molecular Brain Research · doi:10.1016/0169-328x(93)90044-p · Cited by 17
Hoffmann, R., Dawson, N. F., Wade, J. D., & Ötvös, L. (1997) · Journal of Peptide Research · doi:10.1111/j.1399-3011.1997.tb01178.x · Cited by 17
The big tau splice isoform resists Alzheimer’s-related pathological changesPreprint
Chung, D. C., Deng, X., Yalamanchili, H. K., Revelli, J., Han, A. L., Tadros, B., Richman, R., Dias, M., Naini, F. A., Boeynaems, S., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.07.30.605685 · Cited by 16
Davidson, R., Krider, R. I., Borsellino, P., Noorda, K., Alhwayek, G., & Vida, T. A. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45110553 · Cited by 17
“Because the 4R isoforms have an extra one of these binding domains compared to the 3R isoforms, they show a higher affinity to bind microtubules [43].”
BackgroundCompound heterozygosity of 2 novel MAPT mutations in frontotemporal dementia
Anfossi, M., Vuono, R., Maletta, R., Virdee, K., Mirabelli, M., Colao, R., Puccio, G., Bernardi, L., Frangipane, F., Gallo, M., et al. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.12.013 · Cited by 16
“…a region that has previously been associated with the FTDP-17T phenotype, it is located in the loop and not in the stem outside the binding domain of the U6snRNA and in a sequence unlikely to affect the stabilization of the stem (Goedert and Jakes, 1990; Hutton et al., 1998; Poorkaj et al., 1998).”
InfluentialAlafuzoff, I. I. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-63639-3.00010-4 · Cited by 15
Novel monoclonal antibodies targeting the microtubule-binding domain of human tau
Croft, C. L., Moore, B. D., Ran, Y., Chakrabarty, P., Levites, Y., Golde, T. E., & Giasson, B. I. (2018) · PLoS ONE · doi:10.1371/journal.pone.0195211 · Cited by 16
Hromádková, L., & Ovsepian, S. V. (2019) · Journal of Immunology Research · doi:10.1155/2019/7406810 · Cited by 17
“In the CNS, tau protein occurs in six isoforms due to alternative splicing [17] and as a natively unfolded protein which is subjected to many posttranslational modifications, mostly phosphorylation [18].”
Expression and purification of amyloid β-protein, tau, and α-synuclein in Escherichia coli: a review
Jia, L., Zhao, W., Wei, W., Guo, X. L., Wang, W., Wang, Y., Sang, J., Lu, F., & Liu, F. (2020) · Critical Reviews in Biotechnology · doi:10.1080/07388551.2020.1742646 · Cited by 16
“Table 3 shows numbers of studies on the expression and purification of tau along with information of the expression host, vector, yield, media, cultivation, purification strategies, etc. Expression and purification of tau without fusion partners Goedert and Jakes [63] expressed and purified six tau isoforms with a hig…”
MethodTau in the gut, does it really matter?
Derkinderen, P., Rolli‐Derkinderen, M., Chapelet, G., Neunlist, M., & Noble, W. J. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15320 · Cited by 16
“The various splice combinations of tau are thus abbreviated- 0N3R, 0N4R, 1N3R, 1N4R, 2N3R, 2N4R- encoding six proteins isoforms ranging from 352 to 441 amino acids in length (Goedert & Jakes, 1990) (Figure 3).”
BackgroundHuman Induced Pluripotent Stem Cell Models of Frontotemporal Dementia With Tau Pathology
Kühn, R., Mahajan, A., Canoll, P., & Hargus, G. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.766773 · Cited by 18
“In the healthy adult human brain, these 3R and 4R isoforms appear at equal levels (Kosik et al., 1989; Goedert and Jakes, 1990) but in many patients with FTLD-tau including PSP, CBD, AGD, and GGT and including many patients with MAPT mutations, this ratio is shifted toward 4R isoforms (Goedert and…”
BackgroundPhosphorylation Pattern of tau Associated with Distinct Changes of the Growth Cone Cytoskeleton
Šimić, G., Diana, A., & Hof, P. R. (2003) · Progress in molecular and subcellular biology · doi:10.1007/978-3-642-55557-2_2 · Cited by 17
Mutreja, Y., & Gamblin, T. C. (2017) · Methods in cell biology · doi:10.1016/bs.mcb.2017.06.007 · Cited by 17
Ectopic Expression Induces Abnormal Somatodendritic Distribution of Tau in the Mouse Brain
Kubo, A., Ueda, S., Yamane, A., Wada‐Kakuda, S., Narita, M., Matsuyama, M., Nomori, A., Takashima, A., Kato, T., Onodera, O., et al. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.2845-18.2019 · Cited by 17
Janke, C., Beck, M., Holzer, M., Bigl, V., & Arendt, T. (2000) · Brain Research Protocols · doi:10.1016/s1385-299x(00)00018-0 · Cited by 16
Cheng, L. Y., Wang, J., Gong, C., Pei, J.-J., Zaidi, T., Grundke, I., & Iqbal, K. (2001) · Neurochemical Research · doi:10.1023/a:1010963401453 · Cited by 16
Clinicopathological Study of Two Subtypes of Pick’s Disease in Japan
Odawara, T., Iseki, E., Kanai, A., Arai, T., Katsuragi, T., Hino, H., Furukawa, Y., Kato, M., Yamamoto, T., & Kosaka, K. (2002) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000066674 · Cited by 16
Metadata
- Authors
- Goedert, M., & Jakes, R.
- Affiliations
- MRC Laboratory of Molecular Biology (GB)
- ORCID
- Goedert, M.
- Venue
- The EMBO Journal
- Published
- 1990-12-01
- Volume
- 9
- Issue
- 13
- Pages
- 4225-4230
- ISSN
- 0261-4189 (ISSN-L)
- 1460-2075
- PMC
- PMC552204
- OpenAlex
- W1509571186
- Cited by
- 929
- References
- 46
- Citations by year
- 2026: 23 · 2025: 29 · 2024: 50 · 2023: 39 · 2022: 40 · 2021: 53 · 2020: 34 · 2019: 39 · 2018: 42 · 2017: 41 · 2016: 27 · 2015: 37 · 2014: 18 · 2013: 21 · 2012: 25
- FWCI
- 15.03
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The EMBO Journal (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- tau protein, tau isoforms, microtubule-associated proteins, microtubule assembly, tandem repeats, recombinant protein expression, cerebral cortex, fetal brain
- MeSH terms
- Aged, Alkaline Phosphatase, Alzheimer Disease, Amino Acid Sequence, Brain, Escherichia coli, Humans, Isomerism, Microtubule-Associated Proteins, Middle Aged, Molecular Sequence Data, Recombinant Proteins, Repetitive Sequences, Nucleic Acid, RNA Splicing, RNA, Messenger, Tubulin, Mutagenesis, Site-Directed, tau Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review